Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part and are able to give informed consent, as assessed by a short capacity test called the UBACC
- People aged 18 to 65
- People who have been diagnosed with schizophrenia or schizoaffective disorder (based on DSM-5 criteria), confirmed through a structured interview and medical records
- People with at least a 6th grade reading level, as measured by a standard reading test, since reading device instructions is required
- People whose condition and medications have been stable for at least 2 months before joining — meaning no hospital stays and no major medication changes during that time
- People who have at least one person (such as a clinician, case manager, family member, or friend) who has contact with them at least once a month and can provide information about them to the research team
- People who have some level of difficulty with day-to-day functioning — those who are working full-time and are fully financially responsible for their household would not meet this particular criterion
Who may not be able to join:
- People who show more than a moderate level of disorganised thinking, as measured by a specific item on a clinical rating scale called the PANSS
- People who have had an alcohol or substance dependence problem in the past 3 months, based on a DSM-5 interview
- People whose current level of care makes regular outpatient therapy difficult — for example, those who are currently hospitalised or dealing with a serious medical illness
- People who are unable to see well enough or use their hands well enough to operate a smartphone
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amy Pinkham, PhD, The University of Texas at Dallas
Phone: 858-822-4251
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Informant-Rated Specific Level of Function (SLOF) Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.